Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

2024 Home-Study CE: Reversal of Direct Factor-Xa Inhibitors, An Evidence Update


Reversal of Direct Factor-Xa Inhibitors, An Evidence Update

Speaker: Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP, Anticoagulation Stewardship Director, PGY-2 Thrombosis and Hemostasis Management Residency Program Director, Sanford USD Medical Center, Sioux Falls, SD

ACPE Universal Program ID# 0122-0000-24-016-H01-P (Application-based CE)

1 Contact Hours [0.1 CEU]

Release Date: February 12, 2024

Expiration Date: February 12, 2027



CE Hours


CE Units


Activity Type

  • Application

Target Audience(s)

  • Pharmacists


Accreditation Council for Pharmacy Education
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Requirements for CE Credit





There are 2 steps to completing this home-study CE. 
Step 1:  Watch the video presentation in its entirety.
Step 2:  Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.


  • Describe current reversal strategies for direct factor-Xa inhibitors, and the theory behind them
  • Identify critical real-world evidence that has evolved in this practice space, including strengths and weaknesses of the data
  • Compare and contrast the prospective trials than have been conducted with andexanet alfa
  • When presented with a patient with a major bleed on a direct factor-Xa inhibitor, determine an appropriate management strategy


Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP
Program Director, Anticoagulation Services, Sanford USD Medical Center

Activity Number


Release Date: Feb 12, 2024
Credit Expiration Date: Feb 12, 2027

CE Hours